HENDERSON, NV -- (Marketwired) -- 07/21/15 -- United Health Products, Inc. (OTCQB: UEEC), developer, manufacturer and marketer of patented hemostatic gauze for the dental, healthcare, veterinary and wound care sectors, today announced that the Company has engaged Maxim Group LLC, as its new corporate finance advisor. Maxim Group, a leading full-service investment bank, securities and wealth management firm, will assist the Company in determining near term growth strategies to execute their business plan.
Douglas Beplate, Chief Executive Officer of United Health Products, commented, "We are excited to begin working with Maxim. They have assembled a solid team of knowledgeable and experienced industry professionals that we believe will be critical in moving the Company forward in its mission to develop quality, user-friendly and reliable products for the wound care and retail markets. As our Company continues to evolve, having a partner like Maxim Group will help us expand our business and deliver on our overall strategic plan."
About Maxim Group LLC
Maxim Group LLC is a leading full-service investment banking, securities and wealth management firm headquartered in New York. The Firm provides a full array of financial services including investment banking; private wealth management; and global institutional equity, fixed income and derivative sales & trading, equity research and prime brokerage services to a diverse range of corporate clients, institutional investors and high net worth individuals. Maxim Group is a registered broker-dealer with the U.S. Securities and Exchange Commission and the Municipal Securities Rulemaking Board (MSRB), and is a member of the following: Financial Industry Regulatory Authority (FINRA), Securities Insurance Protection Corporation (SIPC), NASDAQ Stock Market and NYSE Arca, Inc. To learn more about Maxim Group, visit www.maximgrp.com.
About United Health Products Inc.
United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com.
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.
United Health Products, Inc.
For Investor Relations
PCG Advisory Group
For Media Relations